News
NIH inventors have developed the first pharmacologic option for developmental stuttering, which is currently only managed by speech therapy, but addresses a $3 billion underserved global market. This technology uses small-molecule iron chelators – drugs that bind and remove excess iron – for the
MedInvest is hosting a Biotech and Pharma Investor Conference September 18-19, 2024 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is
Join the NIH Office of Technology Transfer as a Technology Licensing Monitoring & Enforcement Specialist. This position is located within the Monitoring and Enforcement Unit (MEU) of the Office of Technology Transfer (OTT) within the Office of the Director (OD) at the National Institutes of Health
Are you curious about how innovative technology goes from the laboratory to the marketplace? Do you have a scientific and/or legal background and want to explore other career opportunities? The Technology Transfer Society – Washington D.C. chapter is running an Introduction to Technology Transfer